These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 9876567

  • 1. In vitro evaluation of dissolution properties and degradation products of omeprazole in enteric-coated pellets.
    Storpirtis S, Rodrigues D.
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1101-7. PubMed ID: 9876567
    [Abstract] [Full Text] [Related]

  • 2. Stability of capsules containing omeprazole in enteric coated pellets.
    Palummo M, Cingolani A, Dall L, Volonté MG.
    Boll Chim Farm; 2000 Nov; 139(3):124-8. PubMed ID: 10961022
    [Abstract] [Full Text] [Related]

  • 3. Tableting and stability evaluation of enteric-coated omeprazole pellets.
    Türkoğlu M, Varol H, Celikok M.
    Eur J Pharm Biopharm; 2004 Mar; 57(2):279-86. PubMed ID: 15018985
    [Abstract] [Full Text] [Related]

  • 4. Comparative bioavailability of two enteric-coated capsules of omeprazole in healthy volunteers.
    Garg SK, Chugh Y, Tripathi SK, Kumar N, Sharma PL.
    Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):96-9. PubMed ID: 8458683
    [Abstract] [Full Text] [Related]

  • 5. Dissolution of omeprazole from delayed-release solid oral dosage forms.
    Farinha A, Bica A, Martins JM, Pais JP.
    Drug Dev Ind Pharm; 2000 Jul; 26(7):785-90. PubMed ID: 10872100
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.
    Breier AR, Paim CS, Steppe M, Schapoval EE.
    J Pharm Pharm Sci; 2005 Aug 11; 8(2):289-98. PubMed ID: 16124939
    [Abstract] [Full Text] [Related]

  • 8. Leaky enteric coating on ranitidine hydrochloride beads: dissolution and prediction of plasma data.
    Bendas ER, Ayres JW.
    Eur J Pharm Biopharm; 2008 Aug 11; 69(3):977-85. PubMed ID: 18424095
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Differences in the release of omeprazole in 4 commercial preparations: influence of pH and ionic concentration].
    Navarro MA, Raei N, Torres F, Granero L, García-Zaragoza E, Esplugues JV, Esteban Peris J.
    Gastroenterol Hepatol; 1998 Feb 11; 21(2):63-70. PubMed ID: 9549180
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ, Ayanoglu-Dülger G, Ulusoy NB, Imeryüz N.
    Int J Clin Pharmacol Ther; 1998 Oct 11; 36(10):549-53. PubMed ID: 9799060
    [Abstract] [Full Text] [Related]

  • 13. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer.
    Kibria G, Islam KM, Jalil RU.
    Pak J Pharm Sci; 2009 Jan 11; 22(1):36-43. PubMed ID: 19168418
    [Abstract] [Full Text] [Related]

  • 14. Characterization of enteric-coated tablets and pellets by two in vitro dissolution methods and by scanning electron microscopy.
    Odegårdstuen LI, Bjerknes K, Sande SA, Waaler T.
    Acta Pharm Nord; 1991 Jan 11; 3(3):163-70. PubMed ID: 1793511
    [Abstract] [Full Text] [Related]

  • 15. Comparative bioavailability and in vitro characterization of two brands of diclofenac sodium enteric-coated tablets.
    el-Sayed Y, Suleiman MS, Hasan M, Najib N, Muti H, Abdulhameed M.
    Int J Clin Pharmacol Ther Toxicol; 1988 Oct 11; 26(10):487-91. PubMed ID: 3235214
    [Abstract] [Full Text] [Related]

  • 16. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
    Hosny EA, el-Mahrouk GM, Gouda MW.
    Drug Dev Ind Pharm; 1998 Jul 11; 24(7):661-6. PubMed ID: 9876511
    [Abstract] [Full Text] [Related]

  • 17. Comparative bioavailability of two tablet formulations of diclofenac sodium in normal subjects.
    Hasan MM, Najib NM, Rawashdeh NM, Sallam EN, Shubair MS, Alawneh Y.
    Int J Clin Pharmacol Ther Toxicol; 1991 May 11; 29(5):178-83. PubMed ID: 2071269
    [Abstract] [Full Text] [Related]

  • 18. In vitro study on capsule formulations of omeprazole containing enteric coated granules.
    Pandey VP, Phanindrudu A, Manavalan R, Livingston J.
    Boll Chim Farm; 2002 May 11; 141(6):419-22. PubMed ID: 12577509
    [Abstract] [Full Text] [Related]

  • 19. Establishing Virtual Bioequivalence and Clinically Relevant Specifications for Omeprazole Enteric-Coated Capsules by Incorporating Dissolution Data in PBPK Modeling.
    Yang R, Lin Y, Chen K, Huang J, Yang S, Yao A, Yang X, Lei D, Xiao J, Yang G, Pei Q.
    AAPS J; 2024 Jul 12; 26(4):82. PubMed ID: 38997548
    [Abstract] [Full Text] [Related]

  • 20. The pharmaceutical and biological availability of commercial preparations of furosemide.
    Stüber W, Mutschler E, Steinbach D.
    Arzneimittelforschung; 1982 Jul 12; 32(6):693-7. PubMed ID: 6889429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.